Umayana Biotechnology
PrivateLast Round
Accelerator
Jun 21, 2024
Total Funding Raised
$6,800
Company Overview
Umayana Biotechnology operates in Healthcare & Life Sciences and is based in Turkey. Its latest recorded funding round was an Accelerator round in June 2024.
Umayana Biotechnology is a biotechnology company that develops regenerative medical technologies and patented molecular platforms for the protection, regeneration, and restoration of skin and mucosal tissues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Umayana Biotechnology Comparables
Compare Umayana Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stratpharma AG | 83% | |
| KeraNetics | 79% | |
| BMG Pharma | 78% |
For institutional investors. Book with your work email.
Umayana Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 21, 2024 | ||||
| Grant | Mar 8, 2022 |
For institutional investors. Book with your work email.
Umayana Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CareQuest Innovation Partners | Accelerator |
| United Nations Industrial Development Organization | Accelerator |
| MATTER | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2024
Received funding from CareQuest Innovation Partners and MATTER.
- May 13, 2024
Funding received from TÜBİTAK and UNIDO.
For institutional investors. Book with your work email.
Umayana Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Umayana Biotechnology's valuation, stock price, and market status.
Is Umayana Biotechnology a public or private company?
Umayana Biotechnology is a private company.
What is the current stock price of Umayana Biotechnology?
Umayana Biotechnology is a private company, so its shares have no public market price. Caplight tracks Umayana Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Umayana Biotechnology worth (valuation)?
Valuation information for Umayana Biotechnology is not publicly available.
Can I buy Umayana Biotechnology stock?
Umayana Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Umayana Biotechnology's last funding round?
Umayana Biotechnology's most recent funding round was Accelerator on June 21, 2024.
Who are the main investors in Umayana Biotechnology?
Key investors in Umayana Biotechnology include CareQuest Innovation Partners, United Nations Industrial Development Organization, MATTER.
Will Umayana Biotechnology IPO soon?
No public IPO plans have been announced for Umayana Biotechnology.
How can I track Umayana Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Umayana Biotechnology's shares on secondary markets.